“Novel Sustained-Release Nateglinide Microspheres: In Vitro Evaluation for Improved Antidiabetic Therapy” (2024) Journal of Carcinogenesis, 23(1), pp. 860–870. doi:10.64149/J.Carcinog.24.6s.232-242.